HK1132507A1 - Benzimidazole derivatives as selective acid pump inhibitors - Google Patents
Benzimidazole derivatives as selective acid pump inhibitorsInfo
- Publication number
- HK1132507A1 HK1132507A1 HK10100176.4A HK10100176A HK1132507A1 HK 1132507 A1 HK1132507 A1 HK 1132507A1 HK 10100176 A HK10100176 A HK 10100176A HK 1132507 A1 HK1132507 A1 HK 1132507A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compounds
- disease
- acid pump
- reflux disease
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82644206P | 2006-09-21 | 2006-09-21 | |
US91226407P | 2007-04-17 | 2007-04-17 | |
PCT/IB2007/002749 WO2008035195A1 (en) | 2006-09-21 | 2007-09-17 | Benzimidazole derivatives as selective acid pump inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1132507A1 true HK1132507A1 (en) | 2010-02-26 |
Family
ID=38980958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10100176.4A HK1132507A1 (en) | 2006-09-21 | 2010-01-08 | Benzimidazole derivatives as selective acid pump inhibitors |
Country Status (11)
Country | Link |
---|---|
US (1) | US8466166B2 (de) |
EP (1) | EP2081939B1 (de) |
JP (1) | JP5140080B2 (de) |
KR (1) | KR101109866B1 (de) |
AT (1) | ATE512969T1 (de) |
BR (1) | BRPI0717102A2 (de) |
CA (1) | CA2657550C (de) |
HK (1) | HK1132507A1 (de) |
MX (1) | MX2009000080A (de) |
RU (1) | RU2412188C2 (de) |
WO (1) | WO2008035195A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2624179A1 (en) | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
WO2008114123A1 (en) * | 2007-03-21 | 2008-09-25 | Raqualia Pharma Inc. | Spiro benzimidazole derivatives as acid pump inhibitors |
EP2452680B1 (de) | 2009-07-09 | 2019-12-18 | RaQualia Pharma Inc. | Säurepumpenantagonist zur behandlung von mit unnormalen magen-darm-bewegungen assoziierten erkrankungen |
EA021295B1 (ru) * | 2012-02-29 | 2015-05-29 | Ооо "Фармацевтическая Компания "Славянская Аптека" | Фармацевтический состав, обладающий сосудосуживающим, антиконгестивным, противовоспалительным действием (варианты) |
EA021265B1 (ru) * | 2012-02-29 | 2015-05-29 | Ооо "Фармацевтическая Компания "Славянская Аптека" | Фармацевтический состав, обладающий сосудосуживающим, антиконгестивным, противовоспалительным действием (варианты) |
EA022836B1 (ru) * | 2012-03-02 | 2016-03-31 | ООО "Эн.Си. ФАРМ" | Фармацевтический состав для инъекций, обладающий нейропротекторной, антиамнестической, антиоксидантной, противогипоксической, противоишемической активностью (варианты) |
EA020033B1 (ru) * | 2012-03-11 | 2014-08-29 | Ооо "Эн.Си.Фарм" | Твердая лекарственная форма, обладающая нейропротекторной, антиамнестической, антиоксидантной, противогипоксической, противоишемической активностью (варианты) |
EA020040B1 (ru) * | 2012-03-11 | 2014-08-29 | Ооо "Эн.Си.Фарм" | Твердая лекарственная форма, обладающая нейропротекторной, антиамнестической, антиоксидантной, противогипоксической, противоишемической активностью (варианты) |
EA020042B1 (ru) * | 2012-03-11 | 2014-08-29 | Ооо "Эн.Си.Фарм" | Твердая лекарственная форма, обладающая нейропротекторной, антиамнестической, антиоксидантной, противогипоксической, противоишемической активностью (варианты) |
EA020058B1 (ru) * | 2012-03-14 | 2014-08-29 | Ооо "Эн.Си.Фарм" | Твердая лекарственная форма, обладающая нейропротекторной, антиамнестической, антиоксидантной, противогипоксической, противоишемической активностью (варианты) |
EA021246B1 (ru) * | 2012-03-14 | 2015-05-29 | Ооо "Фармацевтическая Компания "Славянская Аптека" | Фармацевтический состав, обладающий сосудосуживающим, антиконгестивным, противовоспалительным действием (варианты) |
MX2016006657A (es) | 2013-11-22 | 2016-10-12 | CL BioSciences LLC | Antagonistas de gastrina (por ejemplo, yf476, netazepido) para el tratamiento y prevencion de osteoporosis. |
KR20230099093A (ko) * | 2021-12-27 | 2023-07-04 | 에이치케이이노엔 주식회사 | 벤즈이미다졸 유도체의 제조방법 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
GB9518953D0 (en) * | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
WO2000035296A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Improved release of medicament active agents from a chewing gum coating |
GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
US6187777B1 (en) | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
AR043063A1 (es) | 2002-12-13 | 2005-07-13 | Altana Pharma Ag | Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas |
US7307084B2 (en) * | 2003-04-04 | 2007-12-11 | Altana Pharma Ag | Cyclic benzimidazoles |
AR051041A1 (es) * | 2004-10-04 | 2006-12-13 | Altana Pharma Ag | Bencimidazoles triciclicos condensados |
US7449262B2 (en) * | 2004-12-09 | 2008-11-11 | Praxair Technology, Inc. | Current collector to conduct an electrical current to or from an electrode layer |
JP2008534476A (ja) * | 2005-03-24 | 2008-08-28 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 胃腸疾病の治療のために有用なチオアミド置換された三環式のベンゾイミダゾール |
MX2007015087A (es) * | 2005-06-22 | 2008-01-24 | Nycomed Gmbh | Proceso para la produccion de intermediarios para la preparacion de bencimidazoles triciclicos. |
-
2007
- 2007-09-17 JP JP2009528807A patent/JP5140080B2/ja not_active Expired - Fee Related
- 2007-09-17 BR BRPI0717102-1A patent/BRPI0717102A2/pt not_active IP Right Cessation
- 2007-09-17 US US12/442,277 patent/US8466166B2/en active Active
- 2007-09-17 MX MX2009000080A patent/MX2009000080A/es active IP Right Grant
- 2007-09-17 EP EP07825160A patent/EP2081939B1/de not_active Not-in-force
- 2007-09-17 CA CA2657550A patent/CA2657550C/en active Active
- 2007-09-17 RU RU2009114859/04A patent/RU2412188C2/ru not_active IP Right Cessation
- 2007-09-17 AT AT07825160T patent/ATE512969T1/de not_active IP Right Cessation
- 2007-09-17 WO PCT/IB2007/002749 patent/WO2008035195A1/en active Application Filing
- 2007-09-17 KR KR1020097008041A patent/KR101109866B1/ko active IP Right Grant
-
2010
- 2010-01-08 HK HK10100176.4A patent/HK1132507A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MX2009000080A (es) | 2009-01-23 |
ATE512969T1 (de) | 2011-07-15 |
JP2010504317A (ja) | 2010-02-12 |
US8466166B2 (en) | 2013-06-18 |
CA2657550C (en) | 2011-11-01 |
US20100048532A1 (en) | 2010-02-25 |
KR20090054476A (ko) | 2009-05-29 |
KR101109866B1 (ko) | 2012-04-12 |
EP2081939B1 (de) | 2011-06-15 |
RU2009114859A (ru) | 2010-10-27 |
BRPI0717102A2 (pt) | 2013-10-29 |
JP5140080B2 (ja) | 2013-02-06 |
WO2008035195A1 (en) | 2008-03-27 |
CA2657550A1 (en) | 2008-03-27 |
RU2412188C2 (ru) | 2011-02-20 |
EP2081939A1 (de) | 2009-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1132507A1 (en) | Benzimidazole derivatives as selective acid pump inhibitors | |
TW200732326A (en) | Chromane substituted benzimidazole derivatives | |
ATE442140T1 (de) | Chroman-substituierte benzimidazolderivate als säurepumpenantagonisten | |
NZ591793A (en) | Substituted 1-(4-fluoro-5-(2-fluoropyridin-3-yl)-1-((pyrindin-2-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine compounds | |
HK1140484A1 (en) | Solid state forms of racemic ilaprazole | |
CL2008002834A1 (es) | Compuestos heterociclicos de 5 miembros, composicion farmaceutica, util para el tratamiento de la ulcera peptidica, sindrome de zollinger-ellison, gastritis, esofagitis por reflujo, enfermedad sintomatica por reflujo gastroesofagico, esofago de barrett, cancer gastrico, hiperacidez gastrica o ulcera debido a estres posquirurgico. | |
JP2009520017A5 (de) | ||
EE04279B1 (et) | Omeprasooli kristalne vorm | |
IL189375A0 (en) | 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero)aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors | |
CA2671369A1 (en) | Crystal of benzimidazole compound | |
MXPA04000433A (es) | Procedimiento mejorado para preparar compuestos tipo bencimidazol. | |
WO2008059370A8 (en) | Substituted bicyclocarboxyamide compounds | |
WO2011071927A3 (en) | Treatments for gastrointestinal disorders | |
MX2007007010A (es) | Derivados de cromano utiles como antagonistas de la bomba de acido. | |
WO2010038241A3 (en) | Pharmaceutical compositions comprising of proton pump inhibitor, prokinetic agent and alginic acid | |
PT1706383E (pt) | Sal de amina de um derivado de carboestirilo útil para o tratamento de inter alia, úlcera gástrica | |
WO2007072142A3 (en) | Benzimidazole-5-carboxamide derivatives | |
JP2008524199A5 (de) | ||
WO2007026218A3 (en) | Chromane substituted 2-alkyl imidazopyridine derivatives and use thereof as acid pump antagonists | |
UY30205A1 (es) | Derivados de cromano, sales del mismo farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones | |
SE0302382D0 (sv) | New salts II | |
WO2009066309A3 (en) | Process for preparation of omeprazole | |
WO2008015530A3 (en) | Stable solid oral formulation of pantoprazole | |
RU2015106931A (ru) | Лекарственное средство от гастроэзофагеальной рефлюксной болезни | |
WO2008084067A3 (en) | Pharmaceutically active dihydrobenzofurane-substituted benzimidazole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170917 |